TNGX

TANGO THERAPEUTICS INC

TNGX·87583X109·US·Common Stock·Healthcare - Biotechnology-13D/G

TNGX (TANGO THERAPEUTICS INC) is held by 105 institutional investors as of Q1 2026. Largest holders: RTW INVESTMENTS, LP ($278.2M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($268M), FMR LLC ($207.2M). Net institutional sentiment: Mixed.

105
Holders
Avg rating(22 Elite)
$2.2B
Total Value
56% (120)
Fund Consensus
66 buying - 51 selling
TNGXSmart Money Verdict
View all
Held by 105 funds
22 elite
Who's Trading
ActivistNCNextech Crossover I GP S.a. r.l.5.1%May 15, 2026
ActivistRTW Investments, LPRTW Investments, LP9.3%May 15, 2026
ActivistWoodline Partners LPWoodline Partners LP5.6%May 15, 2026
ActivistTCTCG Crossover GP II, LLC8.1%May 15, 2026
ActivistADAdage Capital Management, L.P.9.0%May 13, 2026
ActivistDJDapice Joshua J.7.8%May 11, 2026
InsiderCACrystal AdamExercise 27K shMay 1, 2026
InsiderCACrystal AdamSell $549KMay 1, 2026
InsiderCACrystal AdamSell $24KMay 1, 2026
InsiderGMGall MatthewVest 40K shMay 1, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
13.3M(+791.9%)$278.2M2.8%+177.86%
85
Increased
12.8M(+20.8%)$268M0.4%+269.16%
44
Increased
9.9M(+245.4%)$207.2M0.0%+191.21%
49
Decreased
9.1M(-30.4%)$190.3M1.1%+484.02%
0
Increased
8.7M(+2.4%)$183M0.0%+459.35%
31
Decreased
8M(-20.6%)$167.4M0.6%+389.23%
0
New
5.2M$108M0.0%+170.09%
42
Increased
5.1M(+2.7%)$106.2M0.0%+263.89%
31
Decreased
4.7M(-25.2%)$97.3M0.0%+270.53%
0
New
3.9M$82.3M0.2%+170.09%
49
Decreased
3.8M(-27.5%)$80.1M0.1%+315.72%
0
Increased
2.7M(+4.8%)$56M0.0%+283.30%
31
Decreased
2.4M(-9.4%)$50.1M0.0%+266.94%
0
Increased
1.5M(+3.9%)$30.9M0.0%+270.61%
30
Decreased
1.3M(-7.3%)$27.1M0.0%+283.30%
0
Increased
1.3M(+79.1%)$26.6M0.1%+294.38%
52
New
901,466$18.9M0.0%+170.09%
39
Increased
889,400(+1422.1%)$18.6M0.0%+176.47%
46
Increased
862,940(+7.4%)$18.1M0.0%+335.22%
30
Decreased
838,675(-0.3%)$17.5M0.0%+279.94%
0

Showing 1-20 of 120

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used